Saturday, July 11, 2026

pharma · HR-positive, HER2-negative Advanced Breast Cancer · Hyperglycemia

Chia Tai Tianqing

Chia Tai Tianqing clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Lianyungang, CN
Employees
366
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Programs

Chia Tai Tianqing projects

1 ClinicalTrials.gov programs sponsored by Chia Tai Tianqing.

Chia Tai Tianqing has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TQF3250 placebo

    Chia Tai Tianqing Pharmaceutical Group Co.,

    Hyperglycemia

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Chia Tai Tianqing have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.